Rocket Pharmaceuticals, Inc.

General ticker "RCKT" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.5B (TTM average)

Rocket Pharmaceuticals, Inc. does not follow the US Stock Market performance with the rate: -6.9%.

Estimated limits based on current volatility of 5.0%: low 7.24$, high 8.00$

Factors to consider:

  • Earnings expected soon, date: 2025-05-05 bmo
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [5.19$, 13.61$]
  • 2025-12-31 to 2026-12-31 estimated range: [3.79$, 9.98$]

Financial Metrics affecting the RCKT estimates:

  • Negative: Non-GAAP EPS, $ of -2.73 <= 0.04
  • Negative: Operating cash flow per share per price, % of -14.67 <= 1.79
  • Negative: negative Operating income
  • Positive: Inventory ratio change, % of 0 <= 0
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Interest expense per share, $ of 0.02 <= 0.10

Similar symbols

Short-term RCKT quotes

2025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-024.555.566.577.588.59
Price $

Long-term RCKT plot with estimates

51015202530Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.6−0.4−0.20
RCKTS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $224.34MM $259.66MM $273.20MM
Operating Income $-224.34MM $-259.66MM $-273.20MM
Non-Operating Income $2.48MM $14.06MM $14.46MM
Interest Expense $1.91MM $1.88MM $1.89MM
R&D Expense $165.57MM $180.97MM $171.24MM
Income(Loss) $-221.86MM $-245.59MM $-258.75MM
Profit(Loss)* $-219.38MM $-245.59MM $-258.75MM
Stockholders Equity $489.69MM $492.57MM $463.23MM
Assets $551.81MM $566.34MM $527.70MM
Operating Cash Flow $-178.14MM $-194.92MM $-209.72MM
Capital expenditure $8.62MM $16.47MM $0.00MM
Investing Cash Flow $-69.33MM $-98.07MM $131.71MM
Financing Cash Flow $155.29MM $208.40MM $185.74MM
Earnings Per Share** $-3.22 $-2.92 $-2.73

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.